Table 3. RHAMM is upregulated in non-small cell lung carcinomas, especially in metastatic tumors with statistical significance.

		RHAMM
Tumor type	Total patients	Positive staining	Negative staining	p value
primary	156	89 (57%)	67 (43%)	< 0.001
metastatic	23	22 (96%)	1 (4%)